These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 21913222)
21. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Liu S; Goldstein RH; Scepansky EM; Rosenblatt M Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617 [TBL] [Abstract][Full Text] [Related]
22. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315 [TBL] [Abstract][Full Text] [Related]
23. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
24. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770 [TBL] [Abstract][Full Text] [Related]
25. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo. Schubert A; Hawighorst T; Emons G; Gründker C Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682 [TBL] [Abstract][Full Text] [Related]
26. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
27. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Kim MS; Park MJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH Int J Oncol; 2005 Sep; 27(3):839-46. PubMed ID: 16077936 [TBL] [Abstract][Full Text] [Related]
28. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. Kyutoku M; Taniyama Y; Katsuragi N; Shimizu H; Kunugiza Y; Iekushi K; Koibuchi N; Sanada F; Oshita Y; Morishita R Int J Mol Med; 2011 Aug; 28(2):181-6. PubMed ID: 21617848 [TBL] [Abstract][Full Text] [Related]
29. Cilengitide inhibits metastatic bone colonization in a nude rat model. Bretschi M; Merz M; Komljenovic D; Berger MR; Semmler W; Bäuerle T Oncol Rep; 2011 Oct; 26(4):843-51. PubMed ID: 21725616 [TBL] [Abstract][Full Text] [Related]
30. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo. Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097 [TBL] [Abstract][Full Text] [Related]
31. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. Kurio N; Shimo T; Fukazawa T; Takaoka M; Okui T; Hassan NM; Honami T; Hatakeyama S; Ikeda M; Naomoto Y; Sasaki A Exp Cell Res; 2011 May; 317(8):1134-46. PubMed ID: 21338601 [TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor formation by snake venom disintegrin. Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962 [TBL] [Abstract][Full Text] [Related]
34. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size. Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780 [TBL] [Abstract][Full Text] [Related]
35. HAS2 and CD44 in breast tumorigenesis. Heldin P; Basu K; Kozlova I; Porsch H Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531 [TBL] [Abstract][Full Text] [Related]
36. Transcutaneous carbon dioxide application suppresses bone destruction caused by breast cancer metastasis. Takemori T; Kawamoto T; Ueha T; Toda M; Morishita M; Kamata E; Fukase N; Hara H; Fujiwara S; Niikura T; Kuroda R; Akisue T Oncol Rep; 2018 Oct; 40(4):2079-2087. PubMed ID: 30066936 [TBL] [Abstract][Full Text] [Related]
37. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer. Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395 [TBL] [Abstract][Full Text] [Related]
38. Effect of hyaluronan tetrasaccharides on epidermal differentiation in normal human epidermal keratinocytes. Kage M; Tokudome Y; Matsunaga Y; Hariya T; Hashimoto F Int J Cosmet Sci; 2014 Feb; 36(1):109-15. PubMed ID: 24219060 [TBL] [Abstract][Full Text] [Related]
39. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model. Iwasaki T; Mukai M; Tsujimura T; Tatsuta M; Nakamura H; Terada N; Akedo H Int J Cancer; 2002 Aug; 100(4):381-7. PubMed ID: 12115517 [TBL] [Abstract][Full Text] [Related]
40. Protocadherin-7 induces bone metastasis of breast cancer. Li AM; Tian AX; Zhang RX; Ge J; Sun X; Cao XC Biochem Biophys Res Commun; 2013 Jul; 436(3):486-90. PubMed ID: 23751349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]